Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 5
2005 1
2006 3
2007 4
2008 4
2009 1
2010 1
2011 4
2012 4
2013 3
2014 2
2015 6
2016 3
2017 5
2018 2
2019 8
2020 5
2021 7
2022 9
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
99mTc-Ethylenenediamine-N,N'-diacetic acid/hydrazinonicotinamide[Lys3]-bombesin.
Cheng KT, Ferro-Flores G, Arteaga de Murphy C. Cheng KT, et al. Among authors: ferro flores g. 2007 Aug 15 [updated 2007 Sep 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 Aug 15 [updated 2007 Sep 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641296 Free Books & Documents. Review.
Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
Ferro-Flores G, Arteaga de Murphy C. Ferro-Flores G, et al. Adv Drug Deliv Rev. 2008 Sep;60(12):1389-401. doi: 10.1016/j.addr.2008.04.008. Epub 2008 Apr 23. Adv Drug Deliv Rev. 2008. PMID: 18547675 Review.
[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging.
Rivera-Bravo B, Ramírez-Nava G, Mendoza-Figueroa MJ, Ocampo-García B, Ferro-Flores G, Ávila-Rodríguez MA, Santos-Cuevas C. Rivera-Bravo B, et al. Among authors: ferro flores g. Nucl Med Biol. 2021 May-Jun;96-97:54-60. doi: 10.1016/j.nucmedbio.2021.03.005. Epub 2021 Mar 27. Nucl Med Biol. 2021. PMID: 33831746
Toxicity Assessment of [177Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes.
Hernández-Jiménez T, Cruz-Nova P, Ancira-Cortez A, Gibbens-Bandala B, Lara-Almazán N, Ocampo-García B, Santos-Cuevas C, Morales-Avila E, Ferro-Flores G. Hernández-Jiménez T, et al. Among authors: ferro flores g. Nanomaterials (Basel). 2022 Nov 25;12(23):4181. doi: 10.3390/nano12234181. Nanomaterials (Basel). 2022. PMID: 36500804 Free PMC article.
Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications.
Aranda-Lara L, Isaac-Olivé K, Ocampo-García B, Ferro-Flores G, González-Romero C, Mercado-López A, García-Marín R, Santos-Cuevas C, Estrada JA, Morales-Avila E. Aranda-Lara L, et al. Among authors: ferro flores g. Molecules. 2022 Oct 19;27(20):7046. doi: 10.3390/molecules27207046. Molecules. 2022. PMID: 36296638 Free PMC article.
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses.
Luna-Gutiérrez M, Hernández-Ramírez R, Soto-Abundiz A, García-Pérez O, Ancira-Cortez A, López-Buenrostro S, Gibbens-Bandala B, Soldevilla-Gallardo I, Lara-Almazán N, Rojas-Pérez M, Ocampo-García B, Azorín-Vega E, Santos-Cuevas C, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: ferro flores g. Pharmaceutics. 2023 Jul 20;15(7):1988. doi: 10.3390/pharmaceutics15071988. Pharmaceutics. 2023. PMID: 37514174 Free PMC article.
82 results